Verification evidence is still being completed.
PDF / print export
IDL Diagnostics
Stockholm, Sweden
- Verified lead
- Anders Hultman
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- In Vitro Diagnostics, Oncology Diagnostics, Bacteriology Testing, Tumor Markers, and IVD Products
- Review cycle
- May 2026
- Full address
- Karlsbodavagen 39, 168 67 Bromma Stockholm, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official IDL Diagnostics contact page confirming the Bromma Stockholm address.
- Editorial note
- IDL Diagnostics is published because official company materials confirm current leadership, Stockholm operating address, and a real in-vitro diagnostics platform.
In Vitro Diagnostics, Oncology Diagnostics, Bacteriology Testing, Tumor Markers, and IVD Products
Official leadership disclosure, Official Stockholm address disclosure, IVD platform claim
IDL Diagnostics is published because official company materials confirm current leadership, Stockholm operating address, and a real in-vitro diagnostics platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Stockholm, Sweden
IDL Diagnostics
In Vitro Diagnostics, Oncology Diagnostics, Bacteriology Testing, Tumor Markers, and IVD Products · Diagnostics platform
IDL Diagnostics runs ivd product development, cancer and bacteriology diagnostics, and diagnostics commercial operations in Stockholm, Sweden.
- Lead
- Anders Hultman (verified ↗)
- Address
- Karlsbodavagen 39, 168 67 Bromma Stockholm, Sweden (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Diagnostics platform
- Capabilities
- IVD Product Development · Cancer and Bacteriology Diagnostics · Diagnostics Commercial Operations
- Founded
- 2002
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Anders Hultman
CEO
Full addressKarlsbodavagen 39, 168 67 Bromma Stockholm, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official IDL Diagnostics contact page listing the Bromma Stockholm address.
Open sourceDiagnostics platform
Stockholm, Sweden. In Vitro Diagnostics, Oncology Diagnostics, Bacteriology Testing, Tumor Markers, and IVD Products. Review completed on 22 Mar 2026.
Swedish diagnostics and IVD oversight
Official leadership disclosure, Official Stockholm address disclosure, IVD platform claim
In Vitro Diagnostics, Oncology Diagnostics, Bacteriology Testing, Tumor Markers, and IVD Products
IDL Diagnostics is published because official company materials confirm current leadership, Stockholm operating address, and a real in-vitro diagnostics platform.
Editorial note
IDL Diagnostics is published because official company materials confirm current leadership, Stockholm operating address, and a real in-vitro diagnostics platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
IVD Product Development
Cancer and Bacteriology Diagnostics
Diagnostics Commercial Operations
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
IVD workflow infrastructure
Diagnostics operations systems
Commercial assay support
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is IDL Diagnostics located?
- IDL Diagnostics operates from Karlsbodavagen 39, 168 67 Bromma Stockholm, Sweden, Stockholm, Sweden.
- Who runs IDL Diagnostics?
- IDL Diagnostics is led by Anders Hultman, CEO. Verified 22 Mar 2026.
- What does IDL Diagnostics do?
- IDL Diagnostics runs ivd product development, cancer and bacteriology diagnostics, and diagnostics commercial operations in Stockholm, Sweden. Core capabilities: IVD Product Development, Cancer and Bacteriology Diagnostics, Diagnostics Commercial Operations.
Editorial context
Related technical briefs
Briefs that name Stockholm as a covered market or city.